VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Saved in:
| Title: | VEXAS syndrome: complete molecular remission after hypomethylating therapy. |
|---|---|
| Authors: | Sockel K; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany. katja.sockel@ukdd.de.; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, MunichDresden, Germany. katja.sockel@ukdd.de., Götze K; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, MunichDresden, Germany.; Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Bill M; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany., Georgi JA; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany., Balaian E; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany., Aringer M; Division of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany., Trautmann-Grill K; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany., Uhlig M; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany., Bornhäuser M; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), CHOICE Consortium, Partner Sites, MunichDresden, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT/UCC), Dresden, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Thiede C; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Dresden, Germany.; AgenDix GmbH, Dresden, Germany. |
| Source: | Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 993-997. Date of Electronic Publication: 2024 Jan 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-023-05611-w |
